Zika vaccine research continues in the absence of a large-scale outbreak, but a shortage of cases is making it hard to test for efficacy.

Merck is already in phase 3 testing for its next-generation pneumococcal vaccine, and Pfizer's CFO said his company is "all in" on advancing its…

AstraZeneca’s latest data on its triple-combination COPD candidate may not do much to help it against rival GlaxoSmithKline.

Astellas is reupping its sponsorship of ABC’s “Dancing With the Stars,” partnering with former pro boxer and TV personality Laila Ali.

As it works to turn its business around, Teva picked up an important FDA approval for migraine prevention medication Ajovy.

Sticker prices in drug ads might be off the table again, thanks to some in the U.S. House of Representatives.

Patient groups are asking CVS to reconsider its move to allow clients to exclude drugs based on guidance from drug cost watchdog ICER.

The CD22-directed cytotoxin treatment is AstraZeneca's second approved blood cancer asset, with peak sales estimated at about $500 million.